`Trials@uspto.gov
`571-272-7822 Entered: June 11, 2019
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`COOK INCORPORATED, COOK GROUP INCORPORATED, AND
`COOK MEDICAL LLC,
`Petitioner,
`
`v.
`
`MEDTRONIC, INC.,
`Patent Owner.
`____________
`
`Case IPR2019-00123
`Patent 6,306,141 B1
`____________
`
`
`
`Before JAMESON LEE, KEN B. BARRETT, and
`JAMES A. TARTAL, Administrative Patent Judges.
`
`BARRETT, Administrative Patent Judge.
`
`
`
`
`DECISION
`Institution of Inter Partes Review
`35 U.S.C. § 314
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`I.
`
`INTRODUCTION
`
`A. Background and Summary
`
`
`
`Cook Incorporated, Cook Group Incorporated, and Cook Medical
`
`LLC (collectively, “Petitioner”)1 filed a Petition requesting inter partes
`
`review of U.S. Patent No. 6,306,141 B1 (“the ’141 patent,” Ex. 1001).
`
`Paper 1 (“Pet.”). The Petition challenges the patentability of claims 1–22 of
`
`the ’141 patent. Medtronic, Inc., (“Patent Owner”)2 filed a Preliminary
`
`Response to the Petition. Paper 6 (“Prelim. Resp.”). Petitioner, pursuant to
`
`our authorization, Paper 9, filed a Reply to Patent Owner’s Preliminary
`
`Response, Paper 10 (“Pet. Reply to Prelim. Resp.”).
`
`
`
`An inter partes review may not be instituted “unless . . . the
`
`information presented in the petition . . . shows that there is a reasonable
`
`likelihood that the petitioner would prevail with respect to at least 1 of the
`
`claims challenged in the petition.” 35 U.S.C. § 314(a). Having considered
`
`the arguments and evidence presented by Petitioner and Patent Owner, we
`
`determine that Petitioner has demonstrated a reasonable likelihood of
`
`prevailing in showing that at least one of the challenged claims of the ’141
`
`patent is unpatentable. Accordingly, we institute an inter partes review as to
`
`all the challenged claims of the ’141 patent on all the grounds of
`
`unpatentability set forth in the Petition.
`
`
`
`1 Petitioner identifies Cook Incorporated, Cook Group Incorporated, and
`Cook Medical LLC as real parties-in-interest. Pet. 1.
`2 Patent Owner, under the heading “Real Party-In-Interest,” states that
`Medtronic, Inc. is the owner of the ’141 patent and that “Medtronic plc is the
`ultimate parent of Medtronic, Inc.” Paper 3, 1–2.
`
`2
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`B. Related Proceedings
`
`
`
`One or both parties identify, as matters involving or related to
`
`the ’141 patent, Medtronic, Inc. v. W.L. Gore & Assocs., Inc., No. 06-cv-
`
`04455 (N.D. Cal.), and Medtronic, Inc. v. AGA Med. Corp., No. 07-cv-
`
`00567 (N.D. Cal.) and Patent Trial and Appeal Board cases IPR2013-00269
`
`and IPR2014-00362. Pet. 1; Paper 3.
`
`C. The ’141 Patent
`
`
`
`The ’141 patent pertains to medical devices incorporating shape
`
`memory alloys (SMAs) and, specifically, to medical devices incorporating
`
`stress-induced martensite (SIM) alloys. Ex. 1001, Abstract, 1:21–23.
`
`According to the Abstract of the ’141 patent:
`
`Medical devices which are currently proposed to use
`
`elements made from shape memory alloys may be improved by
`the use of stress-induced martensite alloy elements instead. The
`use of stress-induced martensite decreases the temperature
`sensitivity of the devices, thereby making them easier to install
`and/or remove.
`
`Ex. 1001, Abstract.
`
`
`
`The Specification explains that shape memory alloys were well
`
`known. Id. at 1:26–27. An article made from a shape memory alloy can be
`
`deformed from its original, heat stable configuration to a second, heat
`
`unstable configuration, and, upon application of heat alone, can be caused to
`
`revert to its original configuration. Id. at 1:27–34.
`
`Among metallic alloys, the ability to possess shape
`
`memory is a result of the fact that the alloy undergoes a reversible
`transformation from an austenitic state to a martensitic state with
`a change in temperature. This transformation is sometimes
`referred to as a thermoelastic martensitic transformation. An
`article made from such an alloy, for example a hollow sleeve, is
`easily deformed from its original configuration to a new
`
`3
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`configuration when cooled below the temperature at which the
`alloy is transformed from the austenitic state to the martensitic
`state. The temperature at which this transformation begins is
`usually referred to as Ms and the temperature at which it finishes
`Mf. When an article thus deformed is warmed to the temperature
`at which the alloy starts to revert back to austenite, referred to as
`As (Af being the temperature at which the reversion is complete)
`the deformed object will begin to return to its original
`configuration.
`
`Id. at 1:35–51. The parties refer to the property or behavior associated with
`
`an austenitic-to-martensitic transformation related to a temperature change
`
`as “temperature-induced martensite” or “TIM.” See, e.g., Prelim. Resp. 6;
`
`Pet. 7, 10.
`
`
`
`The Specification further explains that a martensite state also may be
`
`induced by stress:
`
`Many shape memory alloys (SHAs [sic, SMAs]) are
`
`known to display stress-induced martensite (SIM). When an
`SMA sample exhibiting stress-induced martensite is stressed at a
`temperature above Ms (so that the austenitic state is initially
`stable), but below Md (the maximum temperature at which
`martensite formation can occur even under stress) it first deforms
`elastically and then, at a critical stress, begins to transform by the
`formation of stress-induced martensite. Depending on whether
`the temperature is above or below As, the behavior when the
`deforming stress is released differs. If the temperature is below
`As, the stress-induced martensite is stable; but if the temperature
`is above As, the martensite is unstable and transforms back to
`austenite, with the sample returning (or attempting to return) to
`its original shape. The effect is seen in almost all alloys which
`exhibit a thermoelastic martensitic transformation, along with
`the shape memory effect. However, the extent of the temperature
`range over which SIM is seen and the stress and strain ranges for
`the effect vary greatly with the alloy.
`
`4
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`Ex. 1001, 1:52–2:3. “The recoverable deformation associated with the
`
`formation and reversion of stress-induced martensite has been referred to as
`
`pseudoelasticity.” Id. at 4:12–15.
`
`
`
`“Various proposals have also been made to employ shape memory
`
`alloys in the medical field . . . [and t]hese medical SMA devices . . . rely on
`
`the fact that when an SMA element is cooled to its martensitic state and is
`
`subsequently deformed, it will retain its new shape; but when it is warmed to
`
`its austenitic state, the original shape will be recovered.” Id. at 2:15–28.
`
`According to the Specification, there were two principal disadvantages with
`
`this use of SMAs—it was difficult to control the transformation
`
`temperatures of SMAs with accuracy and many SMAs had a large hysteresis
`
`associated with the state transformation thus requiring a significant
`
`temperature excursion to reverse the state. Id. at 2:29–41. Additionally, it
`
`was “inconvenient to have to engage in any temperature manipulation” and
`
`human tissue could be damaged by temperatures outside of narrow limits.
`
`Id. at 2:41–48.
`
`
`
`The ’141 patent purports to disclose the discovery “that if, in a
`
`medical device containing a shape memory alloy element which uses the
`
`shape memory property of that alloy, an element which shows the property
`
`of stress-induced martensite is used instead, an improved device results.” Id.
`
`at 2:59–63. The Specification characterizes the improvement due to the
`
`claimed invention as “compris[ing] the substitution of an alloy element
`
`which displays stress induced martensite at said body temperature for the
`
`shape memory alloy element [in a medical device intended for use in a
`
`mammalian body or a device that is substantially at body temperature].” Id.
`
`at 2:64–3:4.
`
`5
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`
`“Suitable alloy for this invention i.e. those displaying stress-induced
`
`martensite at temperatures near mammalian body temperature (35°–40° C.),
`
`may be selected from known SMAs by those of ordinary skill in theart [sic],
`
`having regard to this disclosure by testing for the existence of the SIM effect
`
`at the desired temperature.” Id. at 4:22–27.
`
`
`
`In the Specification, the Cragg reference3 is discussed as an example
`
`of how a SIM element could be implemented in a medical device using a
`
`shape memory alloy. Id. at 9:10–10:7. In Cragg, an SMA wire, of the alloy
`
`nitinol, was used to form a tubular coiled wire stent4 that was straightened
`
`and introduced into the aorta via a catheter and precisely placed by use of
`
`guide wire upon extrusion from the catheter. Id. at 9:14–49. “Because of
`
`the difficulty of controlling the transformation temperature accurately, it has
`
`proved necessary to cool the straightened wire during insertion and/or to
`
`heat the wire to form the coil after insertion.” Id. at 9:53–56. “These
`
`procedures add to the complexity of the operation.” Id. at 9:56–57.
`
`
`
`To address these issues, the Specification explains that:
`
`If an SIM pseudoelastic wire is used to form the coil,
`
`which is then isothermally deformed by loading into a catheter,
`then the need for temperature control is avoided. The wire
`remains straight when in the catheter, but re-forms the coil
`spontaneously when it is extruded from the catheter. Accurate
`
`
`
`3 Cragg is in the record as Exhibit 1009 and is identified and discussed
`further below.
`4 The described stent is “a compacted nitinol coil [that] is readily positioned
`in a narrowed arterial segment and then expanded to its original form with a
`luminal diameter approximately equal to that of the adjacent, relatively
`normal, blood vessel. Expansion of the coil anchors it against the slightly
`stretched, but otherwise intact, surrounding blood vessel.” Ex. 1001, 9:25–
`32.
`
`6
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`placement is thus readily obtainable, since there is no urgency as
`might be required with a conventional shape memory effect
`element.
`
`Id. at 9:57–65.
`
`D. Illustrative Claim
`
`
`
`Of the challenged claims of the ’141 patent, claims 1, 6, 11, 15, 16,
`
`and 18 are independent claims. The remaining challenged claims depend
`
`directly or indirectly from one of these independent claims. Claim 1,
`
`reproduced below, is illustrative:
`
`1. A medical device for insertion into a mammalian body, the
`device comprising
`
`
`
`(a) a hollow placement device;
`
`(b) a memory alloy element formed at least partly from
`
`pseudoelastic shape-memory alloy,
`the alloy displaying
`reversible stress-induced martensite at about body temperature
`such that it has a stress-induced martensitic state and an
`austenitic state, the memory alloy element having (i) a deformed
`shape when the alloy is in its stress-induced martensitic state and
`(ii) a different unstressed shape when the alloy is in its austenitic
`state; and
`
`
`
`(c) a guide wire;
`
`the memory alloy element being within the hollow
`
`placement device, and the placement device being guidable by
`the guide wire, the hollow placement device stressing the
`memory alloy element at a temperature greater than the As of the
`alloy so that the memory alloy element is in its deformed shape,
`
`wherein the memory alloy element can be extruded from
`
`the hollow placement device by the guide wire at a temperature
`greater than the As of the alloy to transform at least a portion of
`the alloy from its stress-induced martensitic state so that the
`memory alloy element transforms from its deformed shape to its
`unstressed shape, and wherein the alloy is selected so that the
`transformation can occur without any change in temperature of
`the placement device or the memory alloy element.
`
`7
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`Ex. 1001, 10:60–11:20.
`
`
`
`Petitioner relies on the following references:
`
`E. Evidence
`
`Reference
`
`Andrew Cragg et al., Nonsurgical Placement of Arterial
`Endoprostheses: A New Technique Using Nitinol Wire, 147
`RADIOLOGY 261 (1983) (“Cragg”)
`
`Horace Pops, Stress-Induced Pseudoelasticity in Ternary
`Cu-Zn Based Beta Prime Phase Alloys, 1 METALLURGICAL
`TRANSACTIONS 251 (1970) (“Pops”)
`
`U.S. Patent No. 4,490,112; filed Sept. 2, 1982; issued
`Dec. 25, 1984 (“Tanaka”)
`
`Yuichi Suzuki, Shape Memory and Super-elasticity Effects
`in NiTi Alloys, TITANIUM & ZIRCONIUM, Vol. 30, No. 4
`(1982) (“Suzuki”)
`
`Exhibit No.
`
`Ex. 1009
`
`Ex. 1010
`
`Ex. 1011
`
`Ex. 1012
`
`
`
`Petitioner also relies on the Declaration of Kaushik Bhattacharya,
`
`Ph.D, dated September 28, 2018 (Ex. 1021), in support of its arguments.
`
`Patent Owner relies on the Declaration of Dr. Christopher K. Zarins, M.D.,
`
`dated March 12, 2009 (Ex. 2003), filed in earlier litigation, and the
`
`declaration of Dr. Lee Middleman (Ex. 1002, 128–133), filed during the
`
`prosecution of the application that issued as the ’141 patent, in support of its
`
`arguments. The parties rely on other exhibits as discussed below.
`
`F. Asserted Grounds of Unpatentability
`
`
`
`Petitioner asserts the following grounds of unpatentability:
`
`References
`
`Cragg, Pops, and Tanaka
`
`Cragg, Tanaka, and Suzuki
`
`Basis
`
`Claims
`
`§ 103(a) 1–22
`
`§ 103(a) 1–22
`
`8
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`II. ANALYSIS
`
`A. Principles of Law
`
`
`
`Petitioner bears the burden of persuasion to prove unpatentability of
`
`the claims challenged in the Petition, and that burden never shifts to Patent
`
`Owner. Dynamic Drinkware, LLC v. Nat’l Graphics, Inc., 800 F.3d 1375,
`
`1378 (Fed. Cir. 2015).
`
`
`
`A patent claim is unpatentable under 35 U.S.C. § 103(a) if the
`
`differences between the claimed subject matter and the prior art are such that
`
`the subject matter, as a whole, would have been obvious at the time the
`
`invention was made to a person having ordinary skill in the art to which said
`
`subject matter pertains. KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 406
`
`(2007). The question of obviousness is resolved on the basis of underlying
`
`factual determinations including: (1) the scope and content of the prior art;
`
`(2) any differences between the claimed subject matter and the prior art;
`
`(3) the level of skill in the art; and (4) any objective evidence of
`
`non-obviousness. Graham v. John Deere Co., 383 U.S. 1, 17–18 (1966).
`
`B. The Level of Ordinary Skill in the Art
`
`
`
`Petitioner’s declarant, Dr. Bhattacharya, opines that:
`
`[T]he person having ordinary skill in the art (“PHOSITA”) at the
`time the first patent application leading to the ’141 Patent was
`filed on October 14, 1983, would have possessed the knowledge
`and skill known by an engineer, physician, or similar
`professional, having knowledge of, or experience with: (1) shape
`memory alloys exhibiting reversible stress-induced martensite
`behavior, and/or (2) designing medical devices using such shape
`memory alloys.
`
`Ex. 1021 ¶ 18; see Pet. 4. At this stage of the proceeding, Patent Owner
`
`does not disagree. See generally Prelim. Resp. (not addressing explicitly the
`
`level of ordinary skill in the art). Based on the current record and for the
`
`9
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`purposes of this Decision, we adopt Petitioner’s declarant’s proposed
`
`description of the person of ordinary skill in the art. Further, we determine
`
`that the prior art of record reflects the level of skill in the art at the time of
`
`the invention. See Okajima v. Bourdeau, 261 F.3d 1350, 1355 (Fed. Cir.
`
`2001). We will make a final determination as to the level of ordinary skill in
`
`the art, however, based on the full trial record.
`
`C. Claim Construction
`
`
`
`In an inter partes review, claim terms in an unexpired patent are given
`
`their broadest reasonable construction in light of the specification of the
`
`patent in which they appear.5 37 C.F.R. § 42.100(b) (2018)6; see also
`
`Cuozzo Speed Techs. LLC v. Lee, 136 S. Ct. 2131, 2144–46 (2016). “Under
`
`a broadest reasonable interpretation, words of the claim must be given their
`
`plain meaning, unless such meaning is inconsistent with the specification
`
`and prosecution history.” Trivascular, Inc. v. Samuels, 812 F.3d 1056, 1062
`
`(Fed. Cir. 2016).
`
`
`
`In this case, neither party’s brief includes, under the “claim
`
`construction” heading, a proposed construction for any term. Pet. 5; Prelim.
`
`Resp. 14–15. Patent Owner, however, in arguing that Petitioner has failed to
`
`account for a limitation, sets forth a proposed construction as to what it
`
`
`
`5 Patent Owner asserts that the ’141 patent will expire in 2022 and that the
`broadest reasonable construction standard should be applied in this case.
`Prelim. Resp. 14–15; see also Pet. 5 (Petitioner also advocating the
`application of the broadest reasonable construction standard.).
`6 A recent amendment to this rule does not apply here because the Petition
`was filed before November 13, 2018. See Changes to the Claim
`Construction Standard for Interpreting Claims in Trial Proceedings Before
`the Patent Trial and Appeal Board, 83 Fed. Reg. 51,340, 51,340
`(Oct. 11, 2018).
`
`10
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`characterizes as “a key aspect of all the challenged intendent claims.”
`
`Prelim. Resp. 2. Patent Owner contends that “all independent claims require
`
`a device or a component stressing the SIM alloy to induce the martensitic
`
`state and disengaging the SIM alloy from the stress-inducing device or
`
`component to revert the SIM alloy to its austenitic, non-deformed state,
`
`without having to change the temperature.” Id. at 2 n.1; see also id.
`
`at 12, 21.
`
`
`
`We find it helpful to address Patent Owner’s proposed construction.
`
`The following discussion pertains to the language of independent claim 1,
`
`and applies similarly to the other challenged independent claims. Our claim
`
`construction analysis here is preliminary, and we encourage the parties to
`
`address the matters further in future briefing.
`
`1. Patent Owner’s “Disengaging” Position
`
`
`
`Independent claim 1 is an apparatus claim and recites “[a] medical
`
`device” comprising three components. Ex. 1001, 10:60–11:20. Generally
`
`speaking, those three components are: a hollow placement device, a
`
`memory alloy formed from a shape-memory alloy, and a guide wire. Id.
`
`The alloy displays “reversible stress-induced martensite at about body
`
`temperature such that it has a stress-induced martensitic state and an
`
`austenitic state.” Id. at 10:63–67. The claim further recites that the memory
`
`alloy element is within the hollow placement device, and “the hollow
`
`placement device stressing the memory alloy element at a temperature
`
`greater than the As of the alloy so that the memory alloy element is in its
`
`deformed shape.” Id. at 11:6–11; see also id. at 1:47–48 (“As” is the
`
`temperature at which the alloy starts to revert back to austenite).
`
`11
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`
`The last recitation of claim 1, and that which pertains to Patent
`
`Owner’s arguments, see, e.g., Prelim. Resp. 21–22, states:
`
`wherein the memory alloy element can be extruded from
`
`the hollow placement device by the guide wire at a temperature
`greater than the As of the alloy to transform at least a portion of
`the alloy from its stress-induced martensitic state so that the
`memory alloy element transforms from its deformed shape to its
`unstressed shape, and wherein the alloy is selected so that the
`transformation can occur without any change in temperature of
`the placement device or the memory alloy element.
`
`Ex. 1001, 11:12–21 (emphasis added).
`
`
`
`Patent Owner, pointing to this language, argues that “[e]ach
`
`independent claim requires . . . disengaging the SIM alloy from the same
`
`device/restraint (i.e. removing stress) in order to revert the SIM alloy to its
`
`austenitic/unstressed state, without having to change the temperature.”
`
`Prelim. Resp. 21–22 (emphasis in original).
`
`
`
`At this initial stage and on the limited record, we do not agree with
`
`Patent Owner’s argument. First, “disengaging” is an act or step, whereas
`
`claim 1 (as well as each of the other challenged claims) is an apparatus claim
`
`that should be defined by structure, not by acts or steps that may be
`
`performed with or to an apparatus. Second, the claim language quoted
`
`above refers to the structure of the memory alloy element and of the alloy
`
`itself in functional terms—the element “can be extruded” and the alloy “is
`
`selected so that the transformation can occur without any change in
`
`temperature.” The claim does not require the completion of the act of
`
`extruding or the act of transformation, but rather requires structure capable
`
`of performing the recited functions.
`
`
`
`We preliminarily determine that the last recitation of claim 1 requires,
`
`using functional language, a structural relationship defined by, at least, the
`
`12
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`alloy properties, the size and configuration of the memory alloy element
`
`(e.g., the stent), and the size and configuration of the hollow placement
`
`device (e.g., a catheter).
`
`2. Patent Owner’s Arguments Concerning Transformation
`Without the Use of Temperature
`
`
`
`Patent Owner also argues that the claims of the’141 patent “require
`
`stressing and releasing the SIM alloy to effect changes between states
`
`without the use of temperature.” Prelim. Resp. 26; see also id. at 12
`
`(“Importantly, the claims require that the application and removal of stress
`
`induce the transition between austenitic and martensitic states, without any
`
`change in temperature.”). In addition to the questionable assertions that the
`
`claimed apparatus is defined by acts or steps, Patent Owner appears to argue
`
`that the claims preclude an act involving the use of temperature.
`
`
`
`The complete pertinent phrase of claim 1 recites: “the alloy is
`
`selected so that the transformation can occur without any change in
`
`temperature of the placement device or the memory alloy element.”
`
`Ex. 1001, 11:17–20 (emphasis added). Thus, the drafter defined the alloy
`
`functionally as one that is capable of transformation without a temperature
`
`change. On the record before us, it is not clear that the capability to
`
`transform via temperature and the capability to transform via stress are
`
`mutually exclusive. In other words, we cannot determine at this time that a
`
`given alloy could not display both temperature-induced martensite and
`
`stress-induced martensite in appropriate conditions. The Specification
`
`suggests that some shape-memory alloys exhibit both characteristics. See
`
`Ex. 1001, 1:35–2:3 (explaining, inter alia, that “the ability to possess shape
`
`memory is a result of the fact that the alloy undergoes a reversible
`
`transformation from an austenitic state to a martensitic state with a change in
`
`13
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`temperature [and m]any shape memory alloys (SHAs [sic, SMAs]) are
`
`known to display stress-induced martensite (SIM).”); id. at 22–25 (“Suitable
`
`alloy for this invention i.e. those displaying stress-induced martensite at
`
`temperatures near mammalian body temperature (35°—40° C.), may be
`
`selected from known SMAs.”). Thus, it may be that Patent Owner implicitly
`
`is advocating for a limitation based on the intended use of the device. We
`
`decline to construe the challenged apparatus claims as being limited based
`
`on how the apparatus is used.
`
`
`
`In light of the above, we preliminarily determine that claim 1 requires
`
`an alloy having the capability of transformation without a change in
`
`temperature, and that claim 1 does not preclude that same alloy from also
`
`having the capability of transformation due to a temperature change.
`
`
`
`In sum, Petitioner, to meet its burden at this initial stage, must
`
`demonstrate a likelihood of prevailing on its assertion of obviousness of a
`
`device having, inter alia, a memory alloy element that “can be extruded”
`
`from the hollow placement device to transform the device and an alloy
`
`selected such that “the transformation can occur without any change in
`
`temperature.” Ex. 1001, 11:11–20. In other words, the proposed
`
`combination needs to render obvious a device having a structure such that
`
`certain actions can occur, but the prior art need not disclose the actual
`
`occurrence of the act of extruding or the act of transformation without a
`
`change in temperature.
`
`D. The Alleged Obviousness of
`Claims 1–22 Over Cragg, Pops, and Tanaka
`
`
`
`Petitioner alleges that all of the challenged claims of the ’141 patent,
`
`claims 1–22, would have been obvious over Cragg, Pops, and Tanaka. See
`
`14
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`Pet. 17–41 (addressing claim 1). Petitioner relies on Cragg for disclosure of
`
`much of the claimed device and proposes a modification where the alloy of
`
`Pops is substituted for the material used to make Cragg’s stent. See Pet. 14,
`
`31. Petitioner argues that Tanaka discloses the use of such alloys in a
`
`medical device. See id. at 14.
`
`
`
`Patent Owner argues that Petitioner has failed to demonstrate that the
`
`prior art disclosed a “key aspect” of the challenged claims, has failed to
`
`demonstrate “any sufficient motivation to combine” the references, and has
`
`failed “to address known secondary considerations of obviousness.” Prelim.
`
`Resp. 2–4.
`
`
`
`For the reasons that follow, we determine that Petitioner has made an
`
`adequate showing at this stage that at least claim 1 would have been obvious
`
`over Cragg, Pops, and Tanaka.
`
`1. Cragg (Ex. 1009)
`
`
`
`Cragg discloses the use of a coil shaped stent made from a “thermal
`
`shape memory alloy (nitinol).” Ex. 1009, 1. “Nitinol is a specially
`
`formulated alloy of nickel and titanium . . . [with t]he striking property . . .
`
`that it undergoes a phase change at a certain temperature.” Id. “The
`
`‘transition temperature’ is determined by the composition of the alloy.” Id.
`
`The nitinol alloy was drawn into a wire, which was annealed while being
`
`constrained in the desired coil shape. Id.
`
`After cooling, the wire can be straightened and introduced via
`catheter into the body. At or near body temperature the wire
`transforms into its original shape. This property of the wire
`allows one to introduce into the body various complex,
`preformed shapes via catheter.
`
`Id.
`
`15
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`
`The coils of Cragg’s stent, after straightening in ice water, were
`
`fastened to a guide wire to allow accurate placement and were passed
`
`through a catheter to the abdominal aorta. Id. “To minimize transformation
`
`of the wire to its original shape in the catheter, a cold saline solution (10° C)
`
`was flushed continuously through the catheter during introduction of the
`
`wire.” Id. “[T]he wire was extruded from the catheter.” Id.
`
`
`
`Cragg explains:
`
`At room temperature, the nitinol coil is a straight, pliable wire
`that can be passed through a catheter. As the coil is extruded
`from the catheter and warmed to body temperature, it reverts to
`its “memorized” shape, (i.e., a coil). By regulating the
`composition of the alloy, the transition temperature of nitinol
`wire can be adjusted to provide transformation over a narrow
`temperature range (e.g., 36–38° C). The wire we used in this
`study transformed over a broad temperature range (25–38° C),
`which required flushing the introducing catheter with cold saline
`to minimize transformation of the wire in the catheter. We also
`used a 10-F Teflon introducing catheter to reduce friction of the
`partially transformed coil in the catheter. These difficulties can
`be overcome by the development of a wire with a more precise
`transition temperature.
`
`Id. at 2.
`
`
`
`Cragg concludes that, “[w]ith the development of a suitable alloy with
`
`optimal transformation characteristics, nitinol coil grafts may offer a simple,
`
`inexpensive alternative to surgery in numerous forms of cardiovascular
`
`disease.” Id.
`
`16
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`2. Pops (Ex. 1010)
`
`
`
`Pops discloses the composition and testing at various temperatures of
`
`copper-zirconium based shape memory alloys7 with “stress induced
`
`pseudoelastic” (STRIPE) properties. Ex. 1010, 5, 10. Pops states that
`
`“[v]ery large ‘pseudo’ elastic strains are produced as a result of a stress
`
`induced reversible martensitic transformation; the phenomenon may be
`
`called stress induced pseudoelasticity (STRIPE),” and that “[t]he stress
`
`induced martensite phase is elastically balanced within the matrix, so that it
`
`disappears upon unloading.” Id. at 11.
`
`3. Tanaka (Ex. 1011)
`
`
`
`Tanaka discloses “[a]n orthodontic system including an ultraelastic
`
`arch wire [of a nickel-titanium alloy] having a transformation temperature of
`
`normal body temperature of about 37° C.” Ex. 1011, Abstract, 3:67–4:1.
`
`“An ultraelastic material returns to its original shape upon removal of the
`
`deforming load even if deformation of about 8% is imposed during a tensile
`
`test.” Id. at 4:4–7. “This high elastic deformability permits bending or
`
`pulling required for any orthodontic purposes.” Id. at 4:7–8.
`
`In order to provide an orthodontic device having these
`
`desired properties, it is not sufficient merely to utilize an
`ultraelastic Ni-Ti alloy, but it is necessary to select an appropriate
`alloy composition. Additionally, it is necessary to select
`appropriate conditions for the preparation of the orthodontic
`device by appropriate heat treatment. The utlimate [sic]
`properties of the orthodontic device can also vary with the shape
`of the device, for example the diameter of the wire or the cross-
`section. When these factors are appropriately considered with
`
`
`
`7 The parties agree that Pops discloses shape memory alloys. See Pet. 13;
`Prelim. Resp. 16; see also Ex. 1021 ¶ 70.
`
`17
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`respect to one another, it is possible to provide the properties
`required for varying orthodontic purposes.
`
`Id. at 4:21–33.
`
`
`
`Alloys that may be utilized in Tanaka’s device:
`
`are of the “thermoelastic” type having a superlattice and which
`undergo a martensitic transformation. Their ultraelasticity is
`derived from the martensitic transformation caused by stress at a
`temperature
`range above
`the martensitic
`transformation
`temperature and the inverse transformation thereof. There is
`only a small degree of hysteresis in the normal and reverse
`transformation between the austenite and the martensite;
`therefore, these alloys undergo crystallographically reversible
`transformation.
`
`Id. at 4:42–51.
`
`
`
`An ultraeleastic wire is prepared in a straight form and fastened to
`
`tooth 2 to be moved and to normal teeth 3, 4 on either side. Id. at 6:39–40,
`
`48–51, Fig. 3. “Archwire 1 is placed under bending and tensile stresses
`
`along an array of teeth 3, 2 and 4 and a force (or load) which urges wire 1 to
`
`recover its original shape bears on tooth 2 in the direction of the arrow
`
`[shown in Figure 3].” Id. at 6:58–61. The “orthodontic member . . . applies
`
`variable orthodontic load in response to a difference between normal body
`
`temperature and the temperature prevailing upon placement of a temperature
`
`affecting material in the mouth is provided.” Id. at 1:61–66. Tanaka
`
`explains:
`
`Tooth 2 is moved gradually by the load applied thereto and
`aligned correctly. Under normal circumstances, the temperature
`in the mouth is equal to the normal body temperature of 37° C.,
`and therefore, ultraelastic wire 1 in accordance with the invention
`produces only a slight stress or load. However, once hot tea or
`coffee is taken into the mouth, or during a meal, the temperature
`of the wire is raised temporarily to a higher temperature in the
`range of, for example, 50° C. to 60° C. This elevated temperature
`
`18
`
`
`
`IPR2019-00123
`Patent 6,306,141 B1
`
`
`produces a higher stress or load which serves to move tooth 2
`orthdontically. If on the other hand, cold water, ice or any other
`substance having a lower temperature than the normal mouth
`temperature is taken in, wire 1 produces a smaller stress or load
`